Your browser is no longer supported. Please, upgrade your browser.
DXR Daxor Corporation monthly Stock Chart
DXR [AMEX]
Daxor Corporation
Index- P/E- EPS (ttm)-1.16 Insider Own65.60% Shs Outstand3.89M Perf Week-6.12%
Market Cap52.86M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.17M Perf Month-11.90%
Income-4.50M PEG- EPS next Q- Inst Own5.20% Short Float1.13% Perf Quarter-19.53%
Sales0.30M P/S176.19 EPS this Y44.00% Inst Trans215.90% Short Ratio3.65 Perf Half Y-14.77%
Book/sh2.87 P/B4.51 EPS next Y- ROA-27.60% Target Price21.00 Perf Year41.43%
Cash/sh0.00 P/C- EPS next 5Y- ROE-35.40% 52W Range7.85 - 24.08 Perf YTD37.82%
Dividend- P/FCF31.09 EPS past 5Y11.60% ROI- 52W High-46.19% Beta-0.85
Dividend %- Quick Ratio- Sales past 5Y-25.10% Gross Margin-57.80% 52W Low65.03% ATR0.43
Employees37 Current Ratio- Sales Q/Q-50.00% Oper. Margin-97.30% RSI (14)33.75 Volatility3.58% 2.41%
OptionableNo Debt/Eq0.08 EPS Q/Q-425.70% Profit Margin- Rel Volume1.43 Prev Close13.60
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.63K Price12.95
Recom2.00 SMA20-8.37% SMA50-12.16% SMA200-9.22% Volume5,205 Change-4.74%
May-16-19Initiated Ascendiant Capital Markets Buy $20
Nov-19-20 08:30AM  
Oct-29-20 08:30AM  
Oct-12-20 08:30AM  
Oct-08-20 03:30PM  
Oct-06-20 08:30AM  
Oct-05-20 08:30AM  
Oct-02-20 08:30AM  
Sep-28-20 08:57AM  
08:30AM  
Sep-15-20 08:30AM  
Sep-10-20 08:30AM  
Aug-31-20 08:30AM  
Aug-24-20 08:30AM  
Aug-04-20 08:00AM  
Jul-20-20 09:09AM  
Jul-16-20 03:41PM  
08:00AM  
Jul-15-20 08:00AM  
Jul-08-20 08:00AM  
Jun-30-20 08:00AM  
May-29-20 03:34PM  
May-26-20 04:50PM  
May-22-20 08:00AM  
Apr-23-20 08:30AM  
Mar-20-20 08:00AM  
Mar-09-20 08:30AM  
Mar-06-20 08:00AM  
Mar-04-20 09:48AM  
Mar-03-20 09:23AM  
Mar-02-20 08:00AM  
07:55AM  
Feb-20-20 08:30AM  
Feb-12-20 08:00AM  
Dec-31-19 11:20AM  
Nov-21-19 08:00AM  
Nov-12-19 08:00AM  
Oct-29-19 07:37AM  
Oct-15-19 08:00AM  
Oct-10-19 08:30AM  
Sep-24-19 08:00AM  
Sep-19-19 10:15AM  
Sep-18-19 08:00AM  
Sep-11-19 08:00AM  
Sep-04-19 08:00AM  
Aug-30-19 08:59AM  
Aug-06-19 08:00AM  
Jun-18-19 08:00AM  
May-31-19 08:00AM  
May-30-19 08:00AM  
May-27-19 11:28AM  
Mar-21-19 08:30AM  
Mar-15-19 08:30AM  
Mar-04-19 08:30AM  
Feb-22-19 08:37AM  
Feb-13-19 08:30AM  
Jan-23-19 08:30AM  
Jan-10-19 08:30AM  
Nov-13-18 08:30AM  
Nov-08-18 01:46PM  
Nov-07-18 08:30AM  
Nov-01-18 08:30AM  
08:30AM  
Oct-31-18 08:00AM  
Oct-30-18 08:30AM  
Sep-28-18 08:30AM  
Sep-25-18 08:30AM  
Sep-17-18 08:30AM  
Sep-12-18 08:30AM  
Aug-24-18 08:30AM  
Aug-20-18 08:30AM  
Jun-29-18 07:20AM  
Jun-12-18 08:30AM  
Jun-04-18 08:30AM  
May-30-18 08:30AM  
May-29-18 08:30AM  
07:00AM  
May-16-18 07:47PM  
Apr-19-18 09:00AM  
Apr-05-18 09:00AM  
Mar-22-18 09:00AM  
Mar-16-18 08:20AM  
Mar-15-18 02:00PM  
Mar-14-18 08:00AM  
Mar-09-18 11:55AM  
Mar-08-18 12:56PM  
Jan-23-18 03:53PM  
Dec-28-17 04:09PM  
10:47AM  
Dec-27-17 05:55PM  
Dec-21-17 06:00AM  
Nov-21-17 10:09AM  
Nov-01-17 09:00AM  
Sep-15-17 09:00AM  
Jun-29-17 02:44PM  
May-31-17 09:00AM  
May-23-17 12:38PM  
May-03-17 03:51PM  
May-02-17 12:24PM  
Apr-10-17 04:55PM  
Feb-16-17 12:53PM  
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. Daxor Corporation has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences for researching the effectiveness of BVA-100 diagnostic test on quantifying circulatory blood volume in the context of traumatic injury. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.